Further characterization of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in C57BL/6 mice: Role of 5-HT2A serotonergic and α1 adrenergic antagonism

Psychopharmacology

Volumn 203, Issue 2, 2009, Pages 303-315

  Philibin, Scott D ^a   Walentiny, D Matthew ^b   Vunck, Sarah A ^b   Prus, Adam J ^c   Meltzer, Herbert Y ^d   Porter, Joseph H ^b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c NORTHERN MICHIGAN UNIVERSITY   (United States)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

Antipsychotic drugs; Aripiprazole; Chlorpromazine; Clozapine; Fluoxetine; Fluphenazine; Iloperidone; M100907; Melperone; N Desmethylclozapine; Norepinephrine; Olanzapine; Perphenazine; Prazosin; Pyrilamine; Quetiapine; Serotonin; Sertindole; Thioridazine; Zotepine

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; AMPHETAMINE; ARIPIPRAZOLE; CHLORPROMAZINE; CLOZAPINE; DOPAMINE 2 RECEPTOR; FLUOXETINE; FLUPHENAZINE; HALOPERIDOL; HISTAMINE H1 RECEPTOR; ILOPERIDONE; MELPERONE; MEPYRAMINE; NORCLOZAPINE; OLANZAPINE; PERPHENAZINE; PRAZOSIN; QUETIAPINE; QUIPAZINE; RISPERIDONE; RITANSERIN; SCOPOLAMINE; SEROTONIN 2A RECEPTOR; SERTINDOLE; THIORIDAZINE; VOLINANSERIN; ZIPRASIDONE; ZOTEPINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; DRUG RECEPTOR BINDING; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BLOCKING;

ANIMALS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; CONDITIONING, OPERANT; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED C57BL; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, ADRENERGIC, ALPHA-1;

EID: 62449283121     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-008-1385-3     Document Type: Article

References (67)

1. J Arnt T Skarsfeldt 1998 Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence Neuropsychopharmacology 18 63 101
2. Banbury Conference on Genetic Background in Mice 1997 Mutant mice and neuroscience: recommendations concerning genetic background Neuron 19 755 759
3. RG Bilder RS Goldman J Volavka P Czobor M Hoptman B Sheitman JP Lindenmayer L Citrome J McEvoy M Kunz M Chakos TB Cooper TL Horowitz JA Lieberman 2002 Neurocognitive effects of clozapine olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder Am J Psychiatry 159 1018 1028
4. J Bruhwyler JF Liegeois J Bergman G Carey A Goudie A Taylor H Meltzer J Delarge J Geczy 1997 JL13, a pyridobenzoxazepine compound with potential atypical antipsychotic activity: a review of its behavioural properties Pharmacol Res 36 4 255 264
5. LA Bruins Slot L De Vries A Newman-Tancredi D Cussac 2006 Differential profile of antipsychotics at serotonin 5-HT1A and dopamine D2S receptors coupled to extracellular signal-regulated kinase Eur J Pharmacol 18 63 70
6. H Bun B Disdier C Aubert J Catalin 1999 Interspecies variability and drug interactions of clozapine metabolism by microsomes Fundam Clin Pharmacol 13 5 577 81
7. 3 partial agonist J Pharmacol Exp Ther 315 1278 1287
8. 1A/B adrenoceptor subtype selectivity in the rat Eur Neuropsychopharmacol 15 231 234
9. GJ Carey J Bergman 1997 Discriminative-stimulus effects of clozapine in squirrel monkeys: comparison with conventional and novel antipsychotic drugs Psychopharmacology (Berl) 132 261 269
10. JC Cole M Field HR Sumnall AJ Goudie 2007 Potentiation of olanzapine substitution in rats discriminating clozapine by the D2/3 agonist quinpirole Behav Pharmacol 18 3 185 190
11. Colpaert FC, Balster RL (eds). (1988) Transduction mechanisms of drug stimuli. Springer, Berlin
12. JN Crawley 2003 Behavioral phenotyping of rodents Comp Med 53 140 146
13. 1 agonism a pre-requisite for mimicking clozapine's actions? Psychopharmacology 178 451 460
14. 2A antagonist, MDL100,907 Neuropharmacology 44 604 615
15. K Extance AJ Goudie 1981 Inter-animal olfactory cues in operant drug discrimination procedures in rats Psychopharmacology 73 4 363 371
16. D Fiorella S Helsley RA Rabin JC Winter 1997 Further investigations of the interactions of antipsychotics with the (-)2,5-dimethoxy-4-methylamphetamine (DOM) discriminative stimulus Neuropharmacology 36 1463 1469
17. JA Goas JE Boston 1978 Discriminative stimulus properties of clozapine and chlorpromazine Pharmacol Biochem Behav 8 235 241
18. AJ Goudie JA Smith A Taylor MA Taylor MD Tricklebank 1998 Discriminative stimulus properties of the atypical neuroleptic clozapine in rats: tests with subtype selective receptor ligands Behav Pharmacol 9 699 710
19. A Goudie A Taylor 1998 Comparative characterisation of the discriminative stimulus properties of clozapine and other antipsychotics in rats Psychopharmacology (Berl) 135 392 400
20. AJ Goudie JA Smith JC Cole 2004 Stimulus properties of the "atypical" antipsychotic zotepine in rats: comparisons with clozapine and quetiapine Pharmacol Biochem Behav 77 163 173
21. AJ Goudie JA Smith MJ Millan 2004 Characterization of the effects of receptor-selective ligands in rats discriminating the novel antipsychotic quetiapine Psychopharmacology (Berlin) 171 212 222
22. PA Hals H Hall SG Dahl 1986 Phenothiazine drug metabolites: dopamine D2 receptor, alpha 1- and alpha 2-adrenoceptor binding Eur J Pharmacol 125 373 381
23. EM Hoenicke SA Vanecek JH Woods 1992 The discriminative stimulus effects of clozapine in pigeons: involvement of 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors J Pharmacol Exp Ther 263 276 284
24. Holtzman SG (1990) Discriminative stimulus effects of drugs: relationship to potential for abuse. In: Adler MW, Cowan A (eds) Modern methods in pharmacology: testing and evaluation of drugs of abuse. Wiley, New York, pp 193-210
25. A Holmes CC Wrenn AP Harris KE Thayer JN Crawley 2002 Behavioral profiles of inbred strains on novel olfactory, spatial and emotional tests for reference memory in mice Genes Brain Behav 1 55 69
26. T Inoue M Domae K Yamada T Furukawa 1996 Effects of the novel antipsychotic agent 7-(4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy)-3,4- dihydro -2(1H)-quinolinone (OPC-14597) on prolactin release from the rat anterior pituitary gland J Pharmacol Exp Ther 277 137 143
27. 1A receptor Eur J Pharmacol 441 137 140
28. BM Kelley JH Porter 1997 The role of muscarinic cholinergic receptors in the discriminative stimulus properties of clozapine in rats Pharmacol Biochem Behav 57 707 719
29. T Kikuchi K Tottori Y Uwahodo T Hirose T Miwa Y Oshiro S Morita 1995 7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H) -quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity J Pharmacol Exp Ther 274 329 336
30. J Lameh ES Burstein E Taylor DM Weiner KE Vanover DW Bonhaus 2007 Pharmacology of N-desmethylclozapine Pharmacol Ther 115 223 231
31. CP Lawler C Prioleau MM Lewis C Mak D Jiang JA Schetz AM Gonzalez DR Sibley RB Mailman 1999 Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes Neuropsychopharmacology 20 612 627
32. JE Leysen CJ Niemegeers JM Van Nueten PM Laduron 1982 [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role Mol Pharmacol 21 294 300
33. 1 muscarinic receptors Neuropsychopharmacology 30 1986 1995
34. 1A receptor agonist LY293284 in the drug discrimination assay in rats Psychopharmacology 172 415 421
35. HY Meltzer S Matsubara JC Lee 1989 Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values J Pharmacol Exp Ther 251 238 246
36. MJ Millan A Gobert A Newman-Tancredi V Audinot F Lejeune JM Rivet D Cussac JP Nicolas O Muller G Lavielle 1998 S 16924 ((R)-2-[1-[2-(2,3-dihydro- benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol J Pharmacol Exp Ther 286 3 1341 1355
37. 1A agonist properties: II. functional profile in comparison to clozapine and haloperidol J Pharmacol Exp Ther 286 1356 1373
38. 1A agonist properties. IV. a drug discrimination comparison with clozapine J Pharmacol Exp Ther 289 427 436
39. MJ Millan M Brocco JM Rivet V Audinot A Newman-Tancredi L Maiofiss S Queriaux N Despaux JL Peglion A Dekeyne 2000 S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents J Pharmacol Exp Ther 292 54 66
40. 3 receptors Psychopharmacology 191 767 782
41. NA Moore NC Tye MS Axton FC Risius 1992 The behavioral pharmacology of olanzapine, a novel "atypical" antipsychotic agent J Pharmacol Exp Ther 262 545 551
42. S Natesan GE Reckless KBL Barlow JN Nobrega S Kapur 2007 Evaluation of N-desmethylclozapine as a potential antipsychotic-preclinical studies Neuropsychopharmacology 32 7 1540 1549
43. EB Nielsen 1988 Cholinergic mediation of the discriminative stimulus properties of clozapine Psychopharmacology (Berl) 94 115 118
44. F Novi MJ Millan GU Corsini R Maggio 2007 Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N-desmethylclozapine and preclamol at dopamine D2L receptors are modified by co-transfection of D3 receptors: potential role of heterodimer formation J Neurochem 102 1410 1424
45. E-P Palvimaki M Kuoppamaki E Syvalahti J Hietala 1999 Differential effects of fluoxetine and citalopram treatments on serotonin 5-HT2C receptor occupancy in rat brain Int J Neuropsychopharmacol 2 95 99
46. SD Philibin AJ Prus AL Pehrson JH Porter 2005 Serotonin receptor mechanisms mediate the discriminative stimulus properties of the atypical antipsychotic clozapine in C57BL/6 mice Psychopharmacology (Berlin) 180 49 56
47. JH Porter SA Varvel RE Vann SD Philibin LE Wise 2000 Clozapine discrimination with a low training dose distinguishes atypical from typical antipsychotic drugs in rats Psychopharmacology (Berlin) 149 189 193
48. JH Porter AJ Prus RE Vann SA Varvel 2005 Discriminative stimulus properties of the atypical antipsychotic clozapine and the typical antipsychotic chlorpromazine in a three-choice drug discrimination procedure in rats Psychopharmacology (Berlin) 178 67 77
49. JH Porter DM Walentiny SD Philibin SA Vunck JC Crabbe 2008 A comparison of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in DBA/2 and C57BL/6 inbred mice Behav Pharmacol 19(5-6) 530 542
50. AJ Prus LE Baker HY Meltzer 2004 Discriminative stimulus properties of 1.25 mg/kg and 5.0 mg/kg doses of clozapine in rats: examination of the role of dopamine, serotonin and muscarinic receptor mechanisms Pharmacol Biochem Behav 77 199 208
51. AJ Prus SD Philibin AL Pehrson CL Stephens RN Cooper LE Wise JH Porter 2005 Generalization testing with atypical and typical antipsychotic drugs in rats trained to discriminate 5.0 mg/kg clozapine from vehicle in a two-choice drug discrimination task Drug Dev Res 64 55 65
52. AJ Prus SD Philibin AL Pehrson JH Porter 2005 Generalization to atypical antipsychotic drugs depends on training dose in rats trained to discriminate 1.25 mg/kg clozapine versus 5.0 mg/kg clozapine versus vehicle in a three-choice drug discrimination task Behav Pharmacol 16 511 520
53. AJ Prus SD Philibin AL Pehrson JH Porter 2006 Discriminative stimulus properties of the atypical antipsychotic drug clozapine in rats trained to discriminate 1.25 mg/kg clozapine vs. 5.0 mg/kg clozapine vs. vehicle Behav Pharmacol 17 185 194
54. TJ Raedler FP Bymaster R Tandon D Copolov B Dean 2007 Towards a muscarinic hypothesis of schizophrenia Mol Psychiatry 12 232 246
55. Reuters (2008) ACADIA Pharmaceuticals announces results from acp-104 Phase IIb schizophrenia trial. Press Release, June 16, 2008. http://www.reuters.com/article/pressRelease/idUS100572+16-Jun-2008+BW20080616
56. E Richelson A Nelson 1984 Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro E J Pharmacol 103 197 204
57. E Richelson T Souder 2000 Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds Life Sci 68 29 39
58. 4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs Psychopharmacology (Berlin) 120 365 368
59. A Schotte PF Janssen W Gommeren WH Luyten P Van Gompel AS Lesage K De Loore JE Leysen 1996 Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding Psychopharmacology (Berlin) 124 57 73
60. DA Shapiro S Renock E Arrington LA Chiodo LX Liu DR Sibley BL Roth R Mailman 2003 Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology Neuropsychopharmacology 28 1400 1411
61. Tamminga CA, Eamma J, Ibraham H, Jain S, Taylor E, Vanover KE, Hacksell U, Brann M, van Kammen DP (2006) ACP-104 tolerability, safety and pharmacokinetics: single rising dose study. Society for Neuroscience, Atlanta, GA
62. AH Tang SR Franklin CS Himes MW Smith RE Tenbrink 1997 PNU-96415E, a potential antipsychotic agent with clozapine-like pharmacological properties J Pharmacol Exp Ther 281 440 447
63. 2 receptors of normal human brain in vitro Eur J Pharmacol 143 279 282
64. DM Weiner HY Meltzer I Veinbergs EM Donohue TA Spalding TT Smith N Mohell SC Harvey J Lameh N Nash KE Vanover R Olsson K Jayathilake M Lee AI Levey U Hacksell ES Burstein RE Davis MR Brann 2004 The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine Psychopharmacology (Berl) 177 207 216
65. JL Wiley JH Porter 1992 Serotonergic drugs do not substitute for clozapine in clozapine-trained rats in a two-lever drug discrimination procedure Pharmacol Biochem Behav 43 961 965
66. JL Wiley JH Porter 1993 Effects of serotonergic drugs in rats trained to discriminate clozapine from haloperidol Bull Psychon Soc 31 94 96
67. DP Wolfer HP Lipp 2000 Dissecting the behaviour of transgenic mice: is it the mutation, the genetic background, or the environment? Exp Physiol 85 627 634